Janus Henderson Group
NERV icon

Janus Henderson Group’s Minerva Neurosciences NERV Stock Holding History

Janus Henderson Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.9M Buy
4,294,259
+4,285,259
+47,614% +$24.6M 0.01% 552
2025
Q4 		$17.1M Buy
+9,000
New +$33.4K 0.01% 638

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janus Henderson Group's NERV Position: Q1 2026 in Review

Janus Henderson Group increased its Minerva Neurosciences (NERV) stake by 47,614% in Q1 2026, buying an estimated $24.6M and bringing the position to 4,294,259 shares worth $25.9M. The position accounts for 0.01% of the portfolio, ranked #552.

Janus Henderson Group first reported a position in NERV in Q4 2025 and has held it in 2 quarters since. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Janus Henderson Group held 4,294,259 shares of Minerva Neurosciences worth $25.9M as of Q1 2026.
  • Janus Henderson Group bought 4,285,259 Minerva Neurosciences shares in Q1 2026, an estimated $24.6M.
  • Minerva Neurosciences made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #552 holding.
  • Janus Henderson Group first reported a position in Minerva Neurosciences in Q4 2025 and has held it in 2 quarters since.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.